CellAxia Inc.
PrivateLast Round
VC Round
May 31, 2024
Total Funding Raised
$11.3M
Company Overview
CellAxia Inc. is a biopharmaceutical company developing next-generation therapeutics for intractable and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
cell therapyregenerative medicinedrug discoveryrare diseasesorphan drugsintractable diseasesbiotechnologysomatic stem cellsbioventuredrug licensingpharmaceutical R&Dregulatory lymphocytesregen med
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellAxia Inc. Comparables
Compare CellAxia Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healios K.K. | 76% | |
| Rege Nephro Co., Ltd. | 75% | |
| RegCell, Inc. | 74% | |
CellAxia Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 31, 2024 | ||||
| Series C | Aug 19, 2022 | ||||
| Series B | Sep 10, 2020 | ||||
| Seed | Jan 16, 2018 |
CellAxia Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mizuho Capital | Series C, Series B |
| Oita Venture Capital Co., Ltd. | Series C |
| 株式会社FFGベンチャービジネスパートナーズ | Series B |
| Mitsubishi UFJ Capital | Series C, Series B, Seed |
| SBI Okasan Alternative Investment Co., Ltd. | Series C, Series B |
| Miyako Capital | Series C, Series B |
| AJ Capital 株式会社 | Series C |
CellAxia Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CellAxia Inc.'s valuation, stock price, and market status.